Hum. Reprod. Advance Access originally published online on October 6, 2005
Human Reproduction 2006 21(2):421-428; doi:10.1093/humrep/dei315
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tumour necrosis factor-
up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-
B
1 Unité dendocrinologie de la reproduction, Centre de Recherche, Hôpital Saint-François dAssise, Centre Hospitalier Universitaire de Québec, Faculté de Médecine, Université Laval, Québec, Canada, 2 Institute for Medical Research at North Shore-LIJ, NY, USA and 3 Service des Maladies Infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
4 To whom correspondence should be addressed at: Laboratoire dEndocrinologie de la Reproduction, Centre de Recherche, Hôpital Saint-François dAssise, 10 rue de lEspinay, Local D0-711, Québec, Québec, Canada G1L 3L5. E-mail: ali.akoum{at}crsfa.ulaval.ca
BACKGROUND: A series of controlled changes including proliferation, secretion and menstrual shedding occur in the human endometrium during every normal menstrual cycle. Macrophage migration inhibitory factor (MIF), a multifunctional cytokine with numerous proinflammatory, immunomodulatory and angiogenic properties, appears to be expressed in the human endometrium and to follow a regulated cycle phase-dependent expression, but the mechanisms underlying endometrial MIF expression remain to be fully elucidated. METHODS AND RESULTS: Results from enzyme-linked immunosorbent assay (ELISA) demonstrated a significant dose- and time-dependent increase in MIF secretion by human endometrial cells in response to tumour necrosis factor-alpha (TNF-
) (0.1100 ng/ml). This increase was also observed at the mRNA level as shown by reverse transcription (RT)PCR. Curcumin (108 mol/l), a known nuclear factor (NF)-
B inhibitor, inhibited the TNF-
-induced pI
B phosphorylation as shown by western blotting, NF-
B translocation into the nucleus as shown by electrophoretic mobility shift assay, and MIF synthesis and secretion as measured by ELISA and RTPCR. The expression of a dominant-negative NF-
B inhibitor (I
B) significantly decreased the TNF-
-induced MIF promoter activity as analysed by transient cell transfection. CONCLUSIONS: These results indicate clearly that TNF-
up-regulates the expression of MIF in endometrial stromal cells. This took place possibly through NF-
B activation, and may play an important role in the physiology of the human endometrium.
Key words:
endometrium/MIF/NF-
B/TNF-
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Z. Zhao, D. R. Nyholt, L. Le, S. Thomas, C. Engwerda, L. Randall, S. A. Treloar, and G. W. Montgomery Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample Hum. Reprod., September 1, 2007; 22(9): 2389 - 2397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonzalez-Ramos, J. Donnez, S. Defrere, I. Leclercq, J. Squifflet, J.-C. Lousse, and A. Van Langendonckt Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis Mol. Hum. Reprod., July 1, 2007; 13(7): 503 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Arcuri, L. Buchwalder, P. Toti, M. Cintorino, P. Tosi, C. J. Lockwood, B. Rybalov, and F. Schatz Differential Regulation of Colony Stimulating Factor 1 and Macrophage Migration Inhibitory Factor Expression by Inflammatory Cytokines in Term Human Decidua: Implications for Macrophage Trafficking at the Fetal-Maternal Interface Biol Reprod, March 1, 2007; 76(3): 433 - 439. [Abstract] [Full Text] [PDF] |
||||


